12:00 AM
 | 
Jan 16, 2012
 |  BC Week In Review  |  Company News  |  Deals

miRagen, Silence Therapeutics deal

The companies partnered to evaluate delivering miRagen's microRNA therapeutics to tissue using Silence's DBTC delivery system to treat cardiovascular and muscle diseases. miRagen will...

Read the full 98 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >